Expanded Use of Surfactant Therapy in Newborns

Clinics in Perinatology

Volumn 34, Issue 1, 2007, Pages 179-189

  Lacaze Masmonteil, Thierry ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BERACTANT; DEXTRAN; DIPALMITOYLPHOSPHATIDYLCHOLINE; HYALURONIC ACID; LUCINACTANT; MACROGOL; POLYMER; SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYDROPHOBICITY; HYPOXEMIA; LUNG DYSPLASIA; LUNG LAVAGE; MECONIUM ASPIRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; INFANT, NEWBORN; LUNG DISEASES; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33947495783     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2007.01.001     Document Type: Review

References (93)

1. Creuwels L.A., van Golde L.M., and Haagsman H.P. The pulmonary surfactant system: biochemical and clinical aspects. Lung 175 (1997) 1-39
2. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 13 (1999) 1455-1476
3. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochem Biophys Acta 1408 (1998) 79-89
4. Veldhuizen R., Nag K., Orgeis S., et al. The role of lipids in pulmonary surfactant. Biochem Biophys Acta 1408 (1998) 90-108
5. Johansson J., and Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 244 (1997) 675-693
6. Weaver T.E., and Conkright J.J. Function of surfactant proteins B and C. Annu Rev Physiol 63 (2001) 555-578
7. Whitsett J.A., and Weaver T.E. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347 (2002) 2141-2148
8. Hawgood S., Derrick M., and Poulain F. Structure and properties of surfactant protein B. Biochem Biophys Acta 1408 (1998) 150-160
9. Johansson J. Structure and properties of surfactant protein C. Biophys Biochem Acta 1408 (1998) 161-172
10. Ghodrat M. Lung surfactants. Am J Health Syst Pharm 63 (2006) 1504-1521
11. Curstedt T., and Johansson J. New synthetic surfactants-basic science. Biol Neonate 87 (2005) 332-337
12. Halliday H.L. History of surfactant from 1980. Biol Neonate 87 (2005) 317-322
13. Finer N.N. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Respir Rev 5S (2004) S289-S297
14. Lacaze-Masmonteil T. Exogenous surfactant therapy: newer developments. Semin Perinatol 8 (2003) 433-440
15. Whitsett J.A., Wert S.E., and Trapnell B.C. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 13 (2004) R207-R215
16. Whitsett J.A. Genetic disorders of surfactant homeostasis. Paediatr Respir Rev 7S (2006) S240-S242
17. Dargaville P.A., Copnell B., and for the Autralian and New Zealand Neonatal Network. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 117 (2006) 1712-1721
18. Dargaville P.A., and Mills J.F. Surfactant therapy for meconium aspiration syndrome. Drugs 68 (2005) 2569-2591
19. Gunther A., and Seeger W. Resistance to surfactant inactivation. In: Robertson B., and Taeusch H.W. (Eds). Surfactant therapy for lung disease (1995), Dekker, New York 269-292
20. Dargaville P.A., South M., and McDougall P.N. Surfactant and surfactant inhibitor in meconium aspiration syndrome. J Pediatr 138 (2001) 113-115
21. Moses D., Holm B.A., Spitale P., et al. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 164 (1991) 477-481
22. Herting E., Rauprich P., Sticntenoth G., et al. Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 50 (2001) 44-49
23. Sun B., Curstedt T., Song G.W., et al. Surfactant improves lung function and morphology in newborns rabbits with meconium aspiration. Biol Neonate 63 (1993) 96-104
24. Sun B., Curstedt T., and Robertson B. Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 82 (1993) 182-189
25. Sun B., Hertling E., Curstedt T., et al. Exogenous surfactant improves lung compliance and oxygenation in adult rat with mecinium aspiration. J Appl Physiol 77 (1994) 1961-1971
26. Hilgendorff A., Rawer D., Doerner M., et al. Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration. Intensive Care Med 29 (2003) 2247-54
27. Hilgendorff A., Doerner M., Rawer D., et al. Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome. Crit Care Med 34 (2006) 203-210
28. Auten R.L., Notter R.H., Kendig J.W., et al. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87 (1991) 101-107
29. Khammash H., Perlman M., Wojtulewicz J., et al. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 92 (1993) 135-139
30. Halliday H.L., Speer C.P., Robertson B., et al. Treatment of severe meconium aspiration syndrome with porcine surfactant. Eur J Pediatr 155 (1996) 1047-1051
31. Findlay R.D., Taeusch H.W., and Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97 (1996) 48-52
32. Lotze A., Mitchell B.R., Bulas D.I., et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 132 (1998) 40-47
33. Soll R.F., and Dargaville P. Surfactant for meconium aspiration syndrome in full term infants. Cochrane Database Syst Rev 2 (2000) CD002054
34. Chinese Collaborative Study Group for Neonatal Respiratory Diseases. Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicenter randomized controlled trial. Acta Paediatr 94 (2005) 896-902
35. Robinson T.W., and Roberts A.M. Effects of exogenous surfactant on gas exchange and compliance in rabbits after meconium aspiration. Pediatr Pulmonol 33 (2002) 117-123
36. Parenka H.S., Walsh W.F., and Stancombe B.B. Surfactant lavage in a piglet model of meconium aspiration syndrome. Pediatr Res 31 (1992) 625-628
37. Meister J.C., Balaraman V., Ku T., et al. Lavage administration of dilute recombinant surfactant in acute lung injury in piglets. Pediatr Res 47 (2000) 240-245
38. Ibara S., Ikenoue T., Murata Y., et al. Management of meconium aspiration syndrome by tracheobronchial lavage, replacement of surfactant TA. Acta Paediatr Jpn 37 (1995) 64-67
39. Lam B.C.C., Yeung C.Y., Fu K.H., et al. Surfactant tracheobronchial lavage for the management of a rabbit model of meconium aspiration syndrome. Biol Neonate 78 (2000) 129-138
40. Cochrane C.G., Revak S.D., Merritt T.A., et al. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 44 (1998) 705-715
41. Zhang E., Hiroma T., Sahashi T., et al. Airway lavage with exogenous surfactant in an animal model of meconium aspiration syndrome. Pediatr Int 47 (2005) 237-241
42. Lam B.C., and Yeung C.Y. Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 103 (1999) 1014-1018
43. Wiswell T.E., Knight G.R., Finer N.N., et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 109 (2002) 1081-1087
44. Taeusch H.W., Lu K.W., Goerke J., et al. Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 159 (1999) 1391-1395
45. Tashiro K., Kobayashi T., and Robertson B. Dextran reduces surfactant inhibition by meconium. Acta Paediatr 89 (2000) 1439-1445
46. Lu K.W., Robertson B., and Taeush H.W. Dextran or polyethylene glycol added to Curosurf for treatment of meconium lung injury in rats. Biol Neonate 88 (2005) 46-53
47. Lu K.W., Goerke J., Clements J.A., et al. Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury. Pediatr Res 58 (2005) 206-210
48. Ochs M., Schuttler M., Stichtenoth G., et al. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir Res 7 (2006) 86
49. Stichtenoth G., Jung P., Walter G., et al. Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of gram-negative bacteria in vitro. Pediatr Res 59 (2006) 407-411
50. Greenough A., Pulikot A., and Dimitriou G. Prevention and management of meconium aspiration syndrome-assessment of evidence based practice. Eur J Pediatr 164 (2005) 329-330
51. Rubaltelli F.F., Bonafe L., Tangucci M., et al. Epidemiology of neonatal acute respiratory disorders: a multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery. Italian Group of Neonatal Pneumology. Biol Neonate 74 (1998) 7-15
52. Escobar G.J., Clark R.H., and Greene J.D. Short-term outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions. Semin Perinatol 30 (2006) 28-33
53. Madar J., Richmond S., and Hey E. Surfactant-deficiency respiratory distress after elective delivery at "term". Acta Paediatr 88 (1999) 1244-1248
54. Jain L., and Eaton D.C. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol 30 (2006) 28-33
55. Herting E., Jarstrand C., Rasool O., et al. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 36 (1994) 784-791
56. Hertling E., Gan X.Z., Rauprich P., et al. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B Streptococcal pneumonia. Am J Respir Crit Care Med 159 (1999) 1862-1867
57. Hertling E., Sun B., Jarstrang C., et al. Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia. Arch Dis Child 76 (1997) F3-F8
58. Song G.W., Robertson B., Curstedt T., et al. Surfactant treatment in experimental Escherichia coli pneumonia. Acta Anaesthesiol Scand 40 (1996) 1154-1160
59. Herting E., Geffeler O., Land M., et al. Surfactant tretment of neonates with respiratory failure and group B streptococcal infection. Members of the collaborative European Multicenter Study Group. Pediatrics 106 (2000) 957-964
60. Kishore U., Greenhough T.J., Waters P., et al. Surfactant proteins SP-A and SP-D: structure, function and receptor. Mol Immunol 43 (2006) 1293-1315
61. Sano H., and Kuroki Y. The lung collectins, SP-A and SP-D, modulated pulmonary innate immunity. Mol Immunol 42 (2005) 279-287
62. LeVine A.M., Kurak K.E., Wright J.R., et al. Surfactant protein A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20 (1999) 279-286
63. Levine A.M., Whitsett J.A., Gwozdz J.A., et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165 (2000) 3934-3940
64. Hartl D., and Griese M. Surfactant protein D in human lung diseases. Eur J Clin Invest 36 (2006) 423-435
65. Kingma P.S., and Whitsett J.A. In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol 6 (2006) 277-283
66. Papworth S., and Cartlidge P.H.T. Pulmonary haemorrhage. Current Paediatrics 11 (2001) 167-171
67. Raju T.N., and Langenberg P. Pulmonary haemorrhage and exogenous surfactant therapy: a meta-analysis. J Pediatr 123 (1993) 603-610
68. Braun K.R., Davidson K.M., Henry M., et al. Severe pulmonary hemorrhage in the premature infant: analysis of presurfacatnt and surfactant eras. Biol Neonate 75 (1999) 18-30
69. Holm B.A., and Notter R.H. Effects of haemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63 (1987) 1434-1442
70. Kobayashi T., Nitta K., Ganzuka M., et al. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 29 (1991) 353-356
71. Pandit P.B., Dunn M.S., and Colucci E.A. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 95 (1995) 32-36
72. Amizura T., Shimizu H., Niida Y., et al. Surfactant therapy in neonates with respiratory failure due to hemorrhagic pulmonary oedema. Eur J Pediatr 162 (2003) 697-702
73. Rottier R., and Tibboel D. Fetal lung and diaphragm development in congenital diaphragmatic hernia. Semin Perinatol 2 (2005) 86-93
74. Mysore M.R., Margraf L.R., Jaramillo M., et al. Surfactant protein A is decreased in a rat model of congenital diaphragmatic hernia. Am J Respir Crit Care Med 157 (1998) 654-657
75. Van Tuyl M., Blommaart P.E., Keijzer R., et al. Pulmonary surfactant protein A, B, C mRNA and protein expression in the nitrofen-induced congenital diaphragmatic hernia rat model. Pediatr Res 54 (2003) 641-652
76. Wilkox D.T., Glick P.L., Karamanoukian H., et al. Pathophysiology of congenital diaphragmatic hernia. Effect of exogenous surfactant therapy on gas exchange and lung mechanisms in the lamb congenital diaphragmatic hernia model. J Pediatr 124 (1994) 289-893
77. O'Toole S.J., Karamanoukian H.L., Morin F.C., et al. Surfactant decreases pulmonary vascular resistance and increases pulmonary blood flow in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg 31 (1996) 507-511
78. Moya F.R., Thomas V.L., Romaguera J., et al. Fetal lung maturation in congenital diaphragmatic hernia. Am J Obstet Gynecol 173 (1995) 1401-1405
79. Ijsselstijn H., Zimmerman L.J.I., Bunt J.E.H., et al. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluids with congenital diaphragmatic hernia and of age-matched controls. Crit Care Med 26 (1998) 573-580
80. Cogo P.E., Zimmerman L.K.J., Rosso F., et al. Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 166 (2002) 154-158
81. Bae C.W. Exogenous pulmonary surfactant replacement therapy in a neonate with pulmonary hypoplasia accompanying congenital diaphragmatic hernia: a case report. J Korean Med Sci 11 (1996) 265-270
82. Glick P.L., Leach C.L., Besner G.E., et al. Pathophysiology of congenital diaphragmatic hernia: exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg 27 (1992) 866-869
83. Lotze A., Knight G.R., Anderson K.D., et al. Surfactant (Beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg 29 (1994) 407-412
84. Lally K.P., Lally P.A., Langham M.R., et al. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg 39 (2004) 829-833
85. Van Meurs K., and and the Congenital Diaphragmatic Hernia Study Group. Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?. J Pediatr 145 (2004) 312-316
86. Allred T.F., Mercer R.R., Thomas R.F., et al. Brief 95% O2 exposure effects on surfactant protein and mRNA in rat alveolar and bronchiolar epithelium. Am J Physiol 276 (1999) L999-L1009
87. King R.J., Coalson J.J., deLemos R.A., et al. Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 151 (1995) 1989-1997
88. Savani R.C., Godinez R.I., Godinez M.H., et al. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol Lung Cell Mol Physiol 281 (2001) L685-L696
89. Awasthi S., Coalson J.J., Yoder B.A., et al. Deficiencies in lung surfactant protein A and D are associated with lung infection in very premature neonatal baboons. Am J Respir Crit Care Med 163 (2001) 389-397
90. Ballard P.L., Gonzales L.W., Godinez R.I., et al. Surfactant composition and function in a primate model of infant chronic lung disease: effect of inhaled nitric oxide. Pediatr Res 59 (2006) 157-163
91. Merrill J.D., Ballard R.A., Cnaan A., et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 56 (2004) 918-926
92. Pandit P.B., Dunn M.S., Kelley E.N., et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics 95 (1995) 851-854
93. U.S. National Institutes of Health. Pilot trial of surfactant therapy for preterm neonates 5-21 days old with respiratory decompensation. Available at: http://www.clinicaltrials.gov/ct/show/NCT00165074?order=1.